SmartTRAK reports on the latest research and product trends that could potentially impact the market at PSTM 2024.
Advancements in the US Breast Matrices Market continue to unfold as companies work to build the knowledge base about recently introduced biosynthetic breast matrices to help surgeons optimize long-term outcomes and improve the standard of care. At this year’s Plastic Surgery The Meeting (PSTM 24), held September 26-29 in San Diego, California, SmartTRAK identified several research and product trends that could potentially impact the US Breast Matrices Market, particularly in biosynthetic breast matrices. This includes a growing interest in new biosynthetic materials, focusing on long-term aesthetic results, expanding into new indications and using biosynthetics in breast reconstruction.
Among the topics discussed in this informative perspective article are:
- New Materials and Products Driving Growth in Biosynthetics
- According to SmartTRAK, the US Breast Matrices Market will achieve a projected CAGR of +3.5%. However, resorbable biosynthetic matrices are projected to grow ... (read more)
- Focusing on Long-Term Results, Expanded Indications
- At the meeting, several presenters focused on improving the reliability of long-term aesthetic results for cosmetic and reconstructive breast surgery and using biosynthetics in expanded indications ... (read more)
- Using Biosynthetics in Breast Reconstruction
- Making the transition from use in cosmetic surgeries to breast reconstruction is the goal of Integra and BD. Breast reconstruction accounts for 93% of the US Breast Matrices market, primarily because insurance reimbursements remove ... (read more)
Click the button below to download and read the complete "PSTM 2024 Annual Meeting Highlights" perspective article by Doug Devens. SmartTRAK Sr. Product Director/Sr. Analyst - Wound.
